The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Kanes Stephen since year 2005.
The trader's CIK number is 1612859.
At the time of this reporting, Kanes Stephen is the Chief Medical Officer of Sage Therapeutics, Inc. .
(stock ticker symbol SAGE).
See this page for all insider trading activities at Sage Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-01-10||SAGE||Sage Therapeutics, Inc.||Sale||44,000||175.70||7,730,799|
|2018-01-12||SAGE||Sage Therapeutics, Inc.||Option Ex||20,000||.45||9,000|
|2016-04-20||SAGE||Sage Therapeutics, Inc.||Option Ex||21,000||.45||9,450|
|2016-04-19||SAGE||Sage Therapeutics, Inc.||Sale||21,000||38.00||798,000|
|2015-09-28||SAGE||Sage Therapeutics, Inc.||Sale||6,000||46.42||278,520|
|2015-09-28||SAGE||Sage Therapeutics, Inc.||Option Ex||21,000||.45||9,450|
|2015-08-31||SAGE||Sage Therapeutics, Inc.||Sale||12,000||53.12||637,440|
|2015-07-27||SAGE||Sage Therapeutics, Inc.||Option Ex||1,936||.45||871|
|2015-07-27||SAGE||Sage Therapeutics, Inc.||Sale||4,936||70.60||348,471|
|2015-06-24||SAGE||Sage Therapeutics, Inc.||Option Ex||6,000||.45||2,700|
|2015-06-24||SAGE||Sage Therapeutics, Inc.||Sale||6,000||74.06||444,360|
|2015-03-25||SAGE||Sage Therapeutics, Inc.||Sale||5,400||51.49||278,046|
|2015-02-25||SAGE||Sage Therapeutics, Inc.||Sale||6,000||42.05||252,299|
|2015-01-26||SAGE||Sage Therapeutics, Inc.||Sale||6,000||37.29||223,716|
|2014-07-23||SAGE||Sage Therapeutics, Inc.||Buy||3,000||18.00||54,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kanes Stephen (Chief Medical Officer of Sage Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.